317 related articles for article (PubMed ID: 12092782)
1. Teratogenicity of a mutagenised Rift Valley fever virus (MVP 12) in sheep.
Hunter P; Erasmus BJ; Vorster JH
Onderstepoort J Vet Res; 2002 Mar; 69(1):95-8. PubMed ID: 12092782
[TBL] [Abstract][Full Text] [Related]
2. Safety of a mutagen-attenuated Rift Valley fever virus vaccine in fetal and neonatal bovids.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1110-4. PubMed ID: 9328663
[TBL] [Abstract][Full Text] [Related]
3. Adverse response of non-indigenous cattle of European breeds to live attenuated Smithburn Rift Valley fever vaccine.
Botros B; Omar A; Elian K; Mohamed G; Soliman A; Salib A; Salman D; Saad M; Earhart K
J Med Virol; 2006 Jun; 78(6):787-91. PubMed ID: 16628582
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the efficacy and safety of the Rift Valley Fever Clone 13 vaccine in sheep.
Dungu B; Louw I; Lubisi A; Hunter P; von Teichman BF; Bouloy M
Vaccine; 2010 Jun; 28(29):4581-7. PubMed ID: 20470792
[TBL] [Abstract][Full Text] [Related]
5. Hydrops amnii in sheep associated with hydranencephaly and arthrogryposis with wesselsbron disease and rift valley fever viruses as aetiological agents.
Coetzer JA; Barnard BJ
Onderstepoort J Vet Res; 1977 Jun; 44(2):119-26. PubMed ID: 351506
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of a mutagen-attenuated Rift Valley fever virus vaccine in cattle.
Morrill JC; Mebus CA; Peters CJ
Am J Vet Res; 1997 Oct; 58(10):1104-9. PubMed ID: 9328662
[TBL] [Abstract][Full Text] [Related]
7. Pathogenicity and immunogenicity of a mutagen-attenuated Rift Valley fever virus immunogen in pregnant ewes.
Morrill JC; Jennings GB; Caplen H; Turell MJ; Johnson AJ; Peters CJ
Am J Vet Res; 1987 Jul; 48(7):1042-7. PubMed ID: 3631685
[TBL] [Abstract][Full Text] [Related]
8. An inactivated rift valley fever vaccine.
Barnard BJ; Botha MJ
J S Afr Vet Assoc; 1977 Mar; 48(1):45-8. PubMed ID: 874947
[TBL] [Abstract][Full Text] [Related]
9. [Use of veterinary vaccines for preventing and combatting Rift Valley fever: memorandum of a WHO/FAO meeting].
Bull World Health Organ; 1983; 61(3):447-55. PubMed ID: 6603918
[No Abstract] [Full Text] [Related]
10. Rift Valley Fever Vaccine Virus Clone 13 Is Able to Cross the Ovine Placental Barrier Associated with Foetal Infections, Malformations, and Stillbirths.
Makoschey B; van Kilsdonk E; Hubers WR; Vrijenhoek MP; Smit M; Wichgers Schreur PJ; Kortekaas J; Moulin V
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004550. PubMed ID: 27031621
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of a formalin-inactivated Rift Valley fever vaccine in sheep.
Harrington DG; Lupton HW; Crabbs CL; Peters CJ; Reynolds JA; Slone TW
Am J Vet Res; 1980 Oct; 41(10):1559-64. PubMed ID: 7224281
[TBL] [Abstract][Full Text] [Related]
12. Four-segmented Rift Valley fever virus-based vaccines can be applied safely in ewes during pregnancy.
Wichgers Schreur PJ; van Keulen L; Kant J; Kortekaas J
Vaccine; 2017 May; 35(23):3123-3128. PubMed ID: 28457675
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the pathogenicity for pregnant sheep of Rift Valley fever virus and a live attenuated vaccine.
Baskerville A; Hubbard KA; Stephenson JR
Res Vet Sci; 1992 May; 52(3):307-11. PubMed ID: 1620962
[TBL] [Abstract][Full Text] [Related]
14. The use of veterinary vaccines for prevention and control of Rift Valley fever: memorandum from a WHO/FAO meeting.
Bull World Health Organ; 1983; 61(2):261-8. PubMed ID: 6602663
[TBL] [Abstract][Full Text] [Related]
15. Further evaluation of a mutagen-attenuated Rift Valley fever vaccine in sheep.
Morrill JC; Carpenter L; Taylor D; Ramsburg HH; Quance J; Peters CJ
Vaccine; 1991 Jan; 9(1):35-41. PubMed ID: 2008798
[TBL] [Abstract][Full Text] [Related]
16. Ability of a mutagenized virus variant to protect young lambs from Rift Valley fever.
Hubbard KA; Baskerville A; Stephenson JR
Am J Vet Res; 1991 Jan; 52(1):50-5. PubMed ID: 2021254
[TBL] [Abstract][Full Text] [Related]
17. Safety and immunogenicity of a live attenuated Rift Valley Fever recombinant arMP-12ΔNSm21/384 vaccine candidate for sheep, goats and calves.
Boumart Z; Daouam S; Bamouh Z; Jazouli M; Tadlaoui KO; Dungu B; Bettinger G; Watts DM; Elharrak M
Vaccine; 2019 Mar; 37(12):1642-1650. PubMed ID: 30773401
[TBL] [Abstract][Full Text] [Related]
18. Protection of MP-12-vaccinated rhesus macaques against parenteral and aerosol challenge with virulent rift valley fever virus.
Morrill JC; Peters CJ
J Infect Dis; 2011 Jul; 204(2):229-36. PubMed ID: 21673033
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of Rift Valley fever Smithburn and Clone 13 vaccines in calves.
von Teichman B; Engelbrecht A; Zulu G; Dungu B; Pardini A; Bouloy M
Vaccine; 2011 Aug; 29(34):5771-7. PubMed ID: 21664400
[TBL] [Abstract][Full Text] [Related]
20. Rift Valley fever virus vaccine lacking the NSs and NSm genes is safe, nonteratogenic, and confers protection from viremia, pyrexia, and abortion following challenge in adult and pregnant sheep.
Bird BH; Maartens LH; Campbell S; Erasmus BJ; Erickson BR; Dodd KA; Spiropoulou CF; Cannon D; Drew CP; Knust B; McElroy AK; Khristova ML; Albariño CG; Nichol ST
J Virol; 2011 Dec; 85(24):12901-9. PubMed ID: 21976656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
